Omada Health Inc (OMDA) Return on Equity ROE from the third quarter 2026 to third quarter 2025 and annually, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Omada Health Inc   (NASDAQ: OMDA)

Omada Health Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Omada Health Inc in the third quarter 2026?
Omada Health Inc achieved a return on average equity (ROE) of 5.67 % in its third quarter 2026, which is below Omada Health Inc 's average return on equity, which stands at 209.79%.

ROE has advanced compared to 1.84% in the second quarter 2026, due to net income growth.

Within the Medical Equipment & Supplies industry 60 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2026 from 2381 to 2547.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Equity Change 25.68 % 17.98 % - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions 14 4 -6 436 -924
Return On Equity (TTM) 5.67 % 1.84 % -2.81 % 630.34 % -7839.81 %
OMDA's Total Ranking # 2547 # 2381 # 0 # 0 #
Equity (TTM) in Millions 273 253 234 230 217
Seq. Equity Change 8.08 % 7.95 % 1.93 % 5.67 % 1.46 %
Seq. Net Income Change 23.74 % - - - -

Back to OMDA Management Effectiveness >> OMDA's 5 Years Annual ROE >> Compare OMDA ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 61
Sector # 180
Overall # 2547

Return On Equity Statistics
High Average Low
630.34 %
209.79 %
-2.81 %
(Dec 31 2025)   (Mar 31 2026)





OMDA Annual Return On Equity (Dec 31 2025)
2025



Total Equity in Millions 230 0 0 0 0
Y / Y Equity Change - - - - -
Net Income in Millions -13 0 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity -5.56 % - - - -

Back to OMDA Management Effectiveness >> OMDA's 5 Years Annual ROE >> Compare OMDA ROE to its Competitors




More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
OMDA's' Return on Equity at Yahoo Finance
OMDA's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for OMDA's Competitors
Subscribers only: Roe for Omada Health Inc 's Suppliers
Subscribers only: Return On Equity for OMDA's Customers




Companies with similar Return On Equity at Sep 30 2026, within Healthcare Sector ROE
Quest Diagnostics Inc  15.22 %
Regeneron Pharmaceuticals Inc   15.07 %
Bio rad Laboratories Inc   14.07 %
Boston Scientific Corporation  13.75 %
Inspire Medical Systems inc   12.49 %
Haemonetics Corporation  12.07 %
Labcorp Holdings Inc   11.55 %
Henry Schein Inc   11.29 %
Medinotec Inc   10.97 %
Tactile Systems Technology Inc   10.73 %
Penumbra Inc  10.44 %
Teleflex Incorporated  9.67 %
Merit Medical Systems Inc  9.65 %
U S Physical Therapy Inc  9.48 %
Pacific Health Care Organization Inc  8.10 %
Incyte Corporation  7.08 %
Conmed Corporation  7.07 %
Teva Pharmaceutical Industries Limited  6.37 %
Integer Holdings Corporation  6.02 %
Avantor Inc   5.96 %
Ligand Pharmaceuticals Incorporated  5.22 %
Lifestance Health Group Inc   4.82 %
Jazz Pharmaceuticals Plc  4.62 %
Pfizer Inc  4.62 %
Innovage Holding Corp   4.52 %
Icu Medical Inc  2.81 %
Biogen Inc   1.86 %
Integra Lifesciences Holdings Corp  1.24 %

Date modified: 2026-11-07T13:22:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.